| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| RXORXO, Inc. | 2.56B | 15.58 | -7.18 | 15.86% | -1.33% | -5% | 0.41 |
| Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|
| Sales/Revenue | 3.36B | 4.69B | 4.8B | 3.93B | 4.55B |
| Revenue Growth % | - | 0.4% | 0.02% | -0.18% | 0.16% |
| Cost of Goods Sold | 2.82B | 3.95B | 3.94B | 3.2B | 3.77B |
| COGS % of Revenue | 0.84% | 0.84% | 0.82% | 0.82% | 0.83% |
| Gross Profit | 539M | 735M | 860M | 725M | 783M |
| Gross Margin % | 0.16% | 0.16% | 0.18% | 0.18% | 0.17% |
| Gross Profit Growth % | - | 0.36% | 0.17% | -0.16% | 0.08% |
| Operating Expenses | 479M | 543M | 737M | 686M | 839M |
| OpEx % of Revenue | 0.14% | 0.12% | 0.15% | 0.17% | 0.18% |
| Selling, General & Admin | 455M | 539M | 640M | 0 | 0 |
| SG&A % of Revenue | 0.14% | 0.11% | 0.13% | - | - |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - |
| Other Operating Expenses | 24M | 4M | 97M | 686M | 839M |
| Operating Income | 60M | 192M | 123M | 39M | -56M |
| Operating Margin % | 0.02% | 0.04% | 0.03% | 0.01% | -0.01% |
| Operating Income Growth % | - | 2.2% | -0.36% | -0.68% | -2.44% |
| EBITDA | 136M | 273M | 209M | 106M | 31M |
| EBITDA Margin % | 0.04% | 0.06% | 0.04% | 0.03% | 0.01% |
| EBITDA Growth % | - | 1.01% | -0.23% | -0.49% | -0.71% |
| D&A (Non-Cash Add-back) | 76M | 81M | 86M | 67M | 87M |
| EBIT | 57M | 191M | 123M | 67M | 30M |
| Net Interest Income | 0 | 0 | -4M | -32M | -30M |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 4M | 32M | 30M |
| Other Income/Expense | -3M | -1M | -4M | -35M | -248M |
| Pretax Income | 57M | 191M | 119M | 4M | -304M |
| Pretax Margin % | 0.02% | 0.04% | 0.02% | 0% | -0.07% |
| Income Tax | 14M | 41M | 27M | 0 | -14M |
| Effective Tax Rate % | 0.75% | 0.79% | 0.77% | 1% | 0.95% |
| Net Income | 43M | 150M | 92M | 4M | -290M |
| Net Margin % | 0.01% | 0.03% | 0.02% | 0% | -0.06% |
| Net Income Growth % | - | 2.49% | -0.39% | -0.96% | -73.5% |
| Net Income (Continuing) | 43M | 150M | 92M | 4M | -290M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.37 | 1.29 | 0.79 | 0.03 | -2.17 |
| EPS Growth % | - | 2.49% | -0.39% | -0.96% | -65.78% |
| EPS (Basic) | 0.37 | 1.29 | 0.79 | 0.03 | -2.17 |
| Diluted Shares Outstanding | 116.4M | 116.4M | 116.4M | 119.46M | 133.41M |
| Basic Shares Outstanding | 116.4M | 116.4M | 116.4M | 116.87M | 133.41M |
| Dividend Payout Ratio | - | - | - | - | - |
| Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|
| Total Current Assets | 862M | 1.08B | 1.03B | 796M | 1.34B |
| Cash & Short-Term Investments | 70M | 29M | 98M | 5M | 35M |
| Cash Only | 70M | 29M | 98M | 5M | 35M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 772M | 1.01B | 900M | 743M | 1.23B |
| Days Sales Outstanding | 83.94 | 78.62 | 68.49 | 69.06 | 98.43 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - |
| Other Current Assets | 20M | 44M | 31M | 48M | 77M |
| Total Non-Current Assets | 1.01B | 985M | 1B | 1.03B | 2.08B |
| Property, Plant & Equipment | 236M | 239M | 278M | 319M | 411M |
| Fixed Asset Turnover | 14.22x | 19.62x | 17.25x | 12.31x | 11.07x |
| Goodwill | 630M | 630M | 630M | 630M | 1.12B |
| Intangible Assets | 124M | 100M | 79M | 68M | 499M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 18M | 16M | 15M | 12M | 42M |
| Total Assets | 1.87B | 2.07B | 2.03B | 1.82B | 3.41B |
| Asset Turnover | 1.80x | 2.27x | 2.36x | 2.15x | 1.33x |
| Asset Growth % | - | 0.11% | -0.02% | -0.1% | 0.87% |
| Total Current Liabilities | 629M | 816M | 823M | 682M | 1.06B |
| Accounts Payable | 390M | 520M | 501M | 414M | 568M |
| Days Payables Outstanding | 50.51 | 48 | 46.46 | 47.19 | 55.04 |
| Short-Term Debt | 0 | 0 | 4M | 3M | 17M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 5M | 6M | 14M | 13M | 26M |
| Current Ratio | 1.37x | 1.33x | 1.25x | 1.17x | 1.26x |
| Quick Ratio | 1.37x | 1.33x | 1.25x | 1.17x | 1.26x |
| Cash Conversion Cycle | - | - | - | - | - |
| Total Non-Current Liabilities | 173M | 182M | 621M | 549M | 737M |
| Long-Term Debt | 0 | 0 | 451M | 352M | 351M |
| Capital Lease Obligations | 86M | 93M | 114M | 150M | 215M |
| Deferred Tax Liabilities | 49M | 52M | 16M | 7M | 88M |
| Other Non-Current Liabilities | 38M | 37M | 40M | 40M | 83M |
| Total Liabilities | 802M | 998M | 1.44B | 1.23B | 1.8B |
| Total Debt | 116M | 135M | 617M | 558M | 664M |
| Net Debt | 46M | 106M | 519M | 553M | 629M |
| Debt / Equity | 0.11x | 0.13x | 1.05x | 0.94x | 0.41x |
| Debt / EBITDA | 0.85x | 0.49x | 2.95x | 5.26x | 21.42x |
| Net Debt / EBITDA | 0.34x | 0.39x | 2.48x | 5.22x | 20.29x |
| Interest Coverage | - | - | 30.75x | 1.22x | -1.87x |
| Total Equity | 1.07B | 1.07B | 587M | 594M | 1.61B |
| Equity Growth % | - | 0% | -0.45% | 0.01% | 1.71% |
| Book Value per Share | 9.18 | 9.19 | 5.04 | 4.97 | 12.08 |
| Total Shareholders' Equity | 1.07B | 1.07B | 587M | 594M | 1.61B |
| Common Stock | 0 | 0 | 1M | 1M | 2M |
| Retained Earnings | 0 | 0 | 2M | 6M | -284M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -2M | -2M | -4M | -3M | -10M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|
| Cash from Operations | 25M | 155M | 310M | 89M | -12M |
| Operating CF Margin % | 0.01% | 0.03% | 0.06% | 0.02% | -0% |
| Operating CF Growth % | - | 5.2% | 1% | -0.71% | -1.13% |
| Net Income | 43M | 150M | 92M | 4M | -290M |
| Depreciation & Amortization | 76M | 81M | 86M | 67M | 87M |
| Stock-Based Compensation | 8M | 8M | 32M | 19M | 23M |
| Deferred Taxes | -9M | 3M | -20M | -8M | -19M |
| Other Non-Cash Items | 14M | 3M | 6M | 9M | 236M |
| Working Capital Changes | -107M | -90M | 114M | -2M | -49M |
| Change in Receivables | -264M | -242M | 92M | 158M | -109M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 87M | 129M | -14M | -86M | -65M |
| Cash from Investing | -39M | -38M | -56M | -66M | -1.06B |
| Capital Expenditures | -47M | -39M | -57M | -64M | -45M |
| CapEx % of Revenue | 0.01% | 0.01% | 0.01% | 0.02% | 0.01% |
| Acquisitions | - | - | - | - | - |
| Investments | - | - | - | - | - |
| Other Investing | 8M | 1M | 1M | -2M | 0 |
| Cash from Financing | 32M | -158M | -183M | -117M | 1.11B |
| Debt Issued (Net) | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - |
| Other Financing | 32M | -158M | -634M | -16M | -26M |
| Net Change in Cash | - | - | - | - | - |
| Free Cash Flow | -22M | 116M | 253M | 25M | -57M |
| FCF Margin % | -0.01% | 0.02% | 0.05% | 0.01% | -0.01% |
| FCF Growth % | - | 6.27% | 1.18% | -0.9% | -3.28% |
| FCF per Share | -0.19 | 1.00 | 2.17 | 0.21 | -0.43 |
| FCF Conversion (FCF/Net Income) | 0.58x | 1.03x | 3.37x | 22.25x | 0.04x |
| Interest Paid | 0 | 0 | 0 | 32M | 0 |
| Taxes Paid | 2M | 5M | 3M | 27M | 4M |
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Return on Equity (ROE) | 4.03% | 14.03% | 11.1% | 0.68% | -26.29% |
| Return on Invested Capital (ROIC) | 4.04% | 12.58% | 8.09% | 2.6% | -2.48% |
| Gross Margin | 16.06% | 15.68% | 17.93% | 18.46% | 17.21% |
| Net Margin | 1.28% | 3.2% | 1.92% | 0.1% | -6.37% |
| Debt / Equity | 0.11x | 0.13x | 1.05x | 0.94x | 0.41x |
| Interest Coverage | - | - | 30.75x | 1.22x | -1.87x |
| FCF Conversion | 0.58x | 1.03x | 3.37x | 22.25x | 0.04x |
| Revenue Growth | - | 39.68% | 2.28% | -18.12% | 15.86% |
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Truck Brokerage | 2.93B | 2.36B | 3.03B |
| Truck Brokerage Growth | - | -19.49% | 28.46% |
| Last Mile | 1.06B | 1.01B | 1.05B |
| Last Mile Growth | - | -4.43% | 4.04% |
| Freight Forwarding | 422M | 251M | - |
| Freight Forwarding Growth | - | -40.52% | - |
RXO, Inc. (RXO) reported $5.94B in revenue for fiscal year 2024. This represents a 77% increase from $3.36B in 2020.
RXO, Inc. (RXO) grew revenue by 15.9% over the past year. This is strong growth.
RXO, Inc. (RXO) reported a net loss of $79.0M for fiscal year 2024.
RXO, Inc. (RXO) has a return on equity (ROE) of -26.3%. Negative ROE indicates the company is unprofitable.
RXO, Inc. (RXO) had negative free cash flow of $18.0M in fiscal year 2024, likely due to heavy capital investments.